Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
R. A. Sandison, J. D. A. Whitelaw
Journal of Mental Science April 1, 1957 DOI: 10.1192/bjp.103.431.332 via OpenAlex
Summary
AI-generated from the abstractLysergic acid diethylamide (LSD) shows promise in treating mental illness, based on clinical experience gained since an earlier report. The paper describes outcomes from continued use of the drug in therapeutic settings, detailing its effects on patients with various mental disorders. The authors suggest that LSD can facilitate psychological insight and improve symptoms in some cases, though they note limitations and the need for careful administration. The account provides a qualitative assessment of the drug's potential as a treatment tool, grounded in observed patient responses over an extended period.
Study at a glance
| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Population | Patients with mental illness |
| Intervention | Lysergic acid diethylamide |
| Citations | 80 |
| Key finding | LSD shows potential as a therapeutic tool for mental illness, with observed benefits in some patients when administered carefully. |
Abstract
This paper follows a preliminary communication to this Journal two years ago (Sandison, Spencer and Whitelaw, 1954) and gives an account of the fuller experience gained up to the present time with lysergic acid diethylamide in the treatment of mental illness.